A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients.
PHASE4CompletedINTERVENTIONAL
Enrollment
36
Participants
Timeline
Start Date
December 31, 2012
Primary Completion Date
March 31, 2015
Study Completion Date
March 31, 2015
Conditions
HIV
Interventions
DRUG
Darunavir, Ritonavir and Rilpivirine
Trial Locations (1)
SW10 9TH
St Stephen's AIDS Trust, London
All Listed Sponsors
lead
St Stephens Aids Trust
OTHER
NCT01736761 - A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients. | Biotech Hunter | Biotech Hunter